American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2014;37:S81-90.
International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010;33:676-82.
HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008;358:1991-2002.
*Billionnet C, Mitanchez D, Weill A, et al. Gestational diabetes and adverse perinatal outcomes from 716,152 births in France in 2012. Diabetologia 2017;60:636-44.
Avery MD, Walker AJ. Acute effect of exercise on blood glucose and insulin levels in women with gestational diabetes. J Matern Fetal Med 2001;10:52-8.
de Veciana M, Major C, Morgan M. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med 1995;333:1237-41.
*Combs CA, Gunderson E, Kitsmiller JL. Relationship of fetal macrosomia to maternal postprandial glucose control during pregnancy. Diabetes Care 1992;15:1251-7.
Franck M, Philips JC, Emonts P, et al. Contribution of continuous glucose measurement in the management of gestational diabetes: a pilot study. Rev Med Liege 2017;72:295-300.
Heinrichs A, Radermecker R, Paquot N, Philips JC. Evaluation of the accuracy of FreeStyle Libre during gestational diabetes: is this device acceptable for decision making? Acta Diabetol 2020, in press.
Renz PB, Cavagnoli G, Weinert LS, et al. HbA1c test as a tool in the diagnosis of gestational diabetes mellitus. PLoS ONE 2015;10:e0135989
Mendes N, Tavares R, Serrano F. Beyond self-monitored plasma glucose and HbA1c: the role of non-traditional glycaemic markers in gestational diabetes mellitus. J Obstet Gynaecol 2018;38:762-9.
Philips JC, Radermecker R, Rodari A, et al. Facteurs prédictifs de recourir à l'insulinothérapie dans le diabète gestationnel. Présentation au congrès de la Société francophone du diabète, 2019, Marseille, CA-039.
Scheen AJ, Philips JC, Kridelka F. Comment je traite: place de la metformine en gynécologie-obstétrique. Rev Med Liege 2018;73:597-602.
Tarry-Adkins JL, Aiken CE, Ozanne SE. Neonatal, infant, and childhood growth following metformin versus insulin treatment for gestational diabetes: A systematic review and meta-analysis. PLoS Med 2019;16:e1002848.
*Zhao LP, Sheng XY, Zhou S, et al. Metformin versus insulin for gestational diabetes mellitus: a meta-analysis. Br J Clin Pharmacol 2015;80:1224-34.
Langer O, Conway DL, Berkus MD, et al. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 2000;343:1134-8.
Nachum Z, Zafran N, Salim R. Glyburide versus metformin and their combination for the treatment of gestational diabetes mellitus. A randomized controlled study. Diabetes Care 2017;40:332-7.
**Bellamy L, Casas JP, Hingorani A, et al. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 2009;373:1773-9.
Lowe W, Scholtens D, Lowe L, et al. Association of gestational diabetes with maternal disorders of glucose metabolism and childhood adiposity. JAMA 2018;320:1005-16.
Diabetes Prevention Program Research Group. Long-term effects of metformin on diabetes prevention: identification of subgroups that benefited most in the diabetes prevention program and diabetes prevention program outcomes study. Diabetes Care 2019;42:601-8.
Tobias D, Stuart J, Li S, et al. Association of history of gestational diabetes with long-term cardiovascular disease risk in a large prospective cohort of US women. JAMA Intern Med 2017;177:1735-42.
